ProPhase Labs, Inc. (PRPH) has a negative trailing P/E of 0.0, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. The forward P/E of 0.0 based on analyst estimates suggests a return to profitability is expected. Trailing earnings yield is -9,662.40%, forward earnings yield 10,000.00%.
Criteria proven by this page:
Overall SharesGrow Score: 34/100 with 2/7 criteria passed.
| Year | P/E (TTM) | PEG Ratio | P/B Ratio | P/S Ratio | Dividend Yield |
|---|---|---|---|---|---|
| 2015 | -13.4 | 0.25 | 5.47 | 2.35 | - |
| 2016 | -23.3 | 1.02 | 11.20 | 3.18 | - |
| 2017 | 1.6 | 0.00 | 2.12 | 6.85 | - |
| 2018 | -41.3 | 0.39 | 4.35 | 5.47 | 16.30% |
| 2019 | -14.5 | -0.20 | 4.06 | 4.61 | 12.78% |
| 2020 | -25.0 | 1.09 | 5.04 | 3.67 | - |
| 2021 | 8.7 | -0.03 | 0.93 | 0.69 | 8.35% |
| 2022 | 4.1 | 0.02 | 1.20 | 0.62 | 12.25% |
| 2023 | -2.3 | 0.01 | 0.79 | 0.88 | - |
| 2024 | -0.3 | 0.00 | 1.96 | 2.13 | - |
| Year | EPS (Diluted) | Revenue | Net Income | Net Margin |
|---|---|---|---|---|
| 2015 | $-0.22 | $20.6M | $-3.6M | -17.5% |
| 2016 | $-0.17 | $21.01M | $-2.87M | -13.6% |
| 2017 | $2.59 | $9.87M | $41.83M | 423.9% |
| 2018 | $-0.15 | $13.13M | $-1.74M | -13.3% |
| 2019 | $-0.26 | $9.88M | $-3.01M | -30.5% |
| 2020 | $-0.21 | $14.51M | $-2.42M | -16.7% |
| 2021 | $0.40 | $79.04M | $6.27M | 7.9% |
| 2022 | $1.02 | $122.65M | $18.46M | 15.1% |
| 2023 | $-0.98 | $44.38M | $-16.78M | -37.8% |
| 2024 | $-2.43 | $6.77M | $-53.36M | -788.2% |
| Year | EPS (Avg) | EPS Range | Revenue (Avg) | Revenue Range | Analysts |
|---|---|---|---|---|---|
| 2026 | $10.40 | $10.40 – $10.40 | $41.69M | $41.69M – $41.69M | 1 |
